We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

153 hedge funds and large institutions have $332M invested in Filana Therapeutics in 2022 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 50 increasing their positions, 36 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 36

27% more call options, than puts

Call options by funds: $133M | Put options by funds: $105M

0.73% more ownership

Funds ownership: 26.23% → 26.96% (+0.73%)

13% less funds holding

Funds holding: 175 → 153 (-22)

24% less capital invested

Capital invested by funds: $439M → $332M (-$107M)

43% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 42

Holders
153
Holders Change
-22
Holders Change %
-12.57%
% of All Funds
2.46%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
24
Increased
50
Reduced
36
Closed
42
Calls
$133M
Puts
$105M
Net Calls
+$28.1M
Net Calls Change
-$75.1M

Top Buyers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
+$5.9M
2
Group One Trading
Group One Trading
Illinois
+$3.76M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$3.13M
4
Goldman Sachs
Goldman Sachs
New York
+$2.96M
5
N
Nuveen
North Carolina
+$2.91M

Top Sellers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
-$6.58M
2
Bank of America
Bank of America
North Carolina
-$5.93M
3
GC
GMT Capital
Georgia
-$4.81M
4
TI
Think Investments
California
-$4.67M
5
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$4.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
BRWA
176
B. Riley Wealth Advisors
Florida
– -$205K -4,895 Closed
Federated Hermes
177
Federated Hermes
Pennsylvania
– -$174K -4,160 Closed
Simplex Trading
178
Simplex Trading
Illinois
– -$87K -2,422 Closed
BCV
179
Banque Cantonale Vaudoise
Switzerland
– -$84K -2,000 Closed
SAM
180
Shell Asset Management
Netherlands
– -$67K -1,611 Closed
Macquarie Group
181
Macquarie Group
Australia
– -$61K -1,454 Closed
PHK
182
Point72 Hong Kong
Hong Kong
– -$43K -1,031 Closed
ETC
183
Exchange Traded Concepts
Oklahoma
– -$35K -835 Closed
RG
184
Retirement Group
California
– -$32K -760 Closed
CM
185
Caption Management
Oklahoma
– -$21.6K -600 Closed
EPM
186
Equitec Proprietary Markets
Illinois
– -$13K -300 Closed
MAM
187
Meeder Asset Management
Ohio
– -$13K -300 Closed
AF
188
Allworth Financial
California
– -$10K -242 Closed
AIM
189
Axiom Investment Management
New York
– -$8K -200 Closed
HNWAG
190
High Net Worth Advisory Group
Florida
– -$8K -200 Closed
QT
191
Quantbot Technologies
New York
– -$4K -100 Closed
CAL
192
Capital Advisors Ltd
Ohio
– +$11.1K +309 New
4 5 6 7
8

FLNA Hedge Fund Activity: Q4 2022 in Review

153 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q4 2022, worth a combined $332M — down 24% from $439M a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of FLNA and 24 opened new positions — a net loss of 18 holders — while 36 trimmed existing stakes and 50 added.

The largest buyer was Invesco, adding an estimated $5.9M. The largest seller was Marshall Wace, exiting entirely with an estimated $6.58M sold.

  • 153 institutional investors held Filana Therapeutics (FLNA) as of Q4 2022, down from 175 in Q3 2022.
  • Funds reported $332M of Filana Therapeutics stock for Q4 2022, down 24% quarter-over-quarter.
  • 24 funds opened new Filana Therapeutics positions in Q4 2022 and 42 closed out, a net change of -18 holders.
  • The largest Filana Therapeutics buyer in Q4 2022 was Invesco, an estimated $5.9M added.
  • The largest Filana Therapeutics seller in Q4 2022 was Marshall Wace, an estimated $6.58M sold.

Based on aggregated 13F filings for Q4 2022.